NYSEARCA:KURE

KraneShares MSCI All China Health Care Index ETF (KURE) Price, Holdings, & News

$14.70 0.00 (0.00%)
As of 06/18/2026 04:10 PM Eastern

About KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE)

Advanced

Key Stats

Today's Range
$14.70
$14.90
50-Day Range
$14.52
$18.29
52-Week Range
$14.38
$21.88
Volume
9,077 shs
Average Volume
30,352 shs
Market Capitalization
$70.56 million
Assets Under Management
$67.27 million
Dividend Yield
4.83%
Net Expense Ratio
0.65%
Aggregate Rating
Moderate Buy

ETF Overview

KraneShares MSCI All China Health Care Index ETF Expenses

TypeKUREHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.78%0.56%0.57%0.51%0.53%
Other Expenses0.01%0.47%0.55%0.58%0.55%
Total Expense0.79%0.74%0.76%0.74%0.73%
Fee Waiver-0.14%-0.71%-0.64%-0.70%-0.62%
Net Expense0.65%0.59%0.63%0.58%0.60%
Receive KURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KraneShares MSCI All China Health Care Index ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KURE ETF News Headlines

KURE: Capitalizing On China's Healthcare Revolution
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillion in stored capital will be looking for a home when it does. But the real opportunity isn't the IPO itself. Jovine has identified a small-cap supplier trading near $4 that sits directly in the path of xAI's Colossus infrastructure buildout - and a specific trigger in the S-1 could reprice it overnight.tc pixel
See More Headlines

KURE ETF - Frequently Asked Questions

KraneShares MSCI All China Health Care Index ETF's stock was trading at $17.04 at the beginning of 2026. Since then, KURE stock has decreased by 13.7% and is now trading at $14.70.

Shares of KURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that KraneShares MSCI All China Health Care Index ETF investors own include Alibaba Group (BABA), NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Visa (V), Micron Technology (MU) and Tesla (TSLA).

Fund Details

Issuer
KraneShares
Fund Name
KraneShares MSCI All China Health Care Index ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:KURE
Inception Date
1/31/2018
Fund Manager
Mark Schlarbaum
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
MSCI China All Shares Health Care 10/40 Index
Category
Sector
Focus
Health Care
Development Level
Emerging Markets
Region
Asia-Pacific
Number of Holdings
55

Fund Statistics

Assets Under Management
$67.27 million
Average Daily Volume
$21.33 thousand
Discount/Premium
-0.08%

Administrator, Advisor and Custodian

Administrator
SEI Investments Global Funds Services
Advisor
Krane Funds Advisors, LLC
Custodian
Brown Brothers Harriman & Co.
Distributor
SEI Investments Distribution Co.
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
GTS

Options

Optionable
Optionable
Options Volume
2
Put Options
0
Call Options
2

Miscellaneous

Beta
0.20
Creation Unit
50,000
Creation Fee
$1,320.00
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Top 10 KURE Holdings

  • BeOne Medicines AG
    Holding Weight: 9.20%
  • Innovent Biologics, Inc.
    Holding Weight: 8.36%
  • WuXi Biologics (Cayman) Inc.
    Holding Weight: 7.44%
  • WuXi AppTec Co., Ltd.
    Holding Weight: 5.90%
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    Holding Weight: 4.49%
  • Jiangsu Hengrui Pharmaceuticals Co.,Ltd
    Holding Weight: 4.47%
  • CSPC Pharmaceutical Group Limited
    Holding Weight: 4.00%
  • Akeso, Inc.
    Holding Weight: 3.83%
  • WuXi AppTec Co., Ltd.
    Holding Weight: 3.51%
  • Sino Biopharmaceutical Limited
    Holding Weight: 3.48%

KURE Sector Exposure

KURE Industry Exposure


This page (NYSEARCA:KURE) was last updated on 6/21/2026 by MarketBeat.com Staff.
From Our Partners